Context Therapeutics Appoints Two New Board Members
04 Sep 2024 //
GLOBENEWSWIRE
Jazz Pharma stops enrollment in phase 3 study evaluating defibrotide
04 May 2020 //
PHARMABIZ
Jazz Stops Enrollment in Phase 3 Study Evaluating Defibrotide
29 Apr 2020 //
PRESS RELEASE